Biochemical Pharmacology · 2012 · 55 citations · 34 references
MedicineOncologyPharmacologyCancer PharmacologyMedical OncologyMolecular OncologyPharmacodynamics Of Anticancer AgentsTargeted Cancer TherapyTargeted TherapyTopoisomerase InhibitorsTopoisomerase ActivityTopoisomerase Ii InhibitorsTopoisomerase Targets
34
Improved protein–ligand docking using GOLD
Marcel L. Verdonk, Jason C. Cole, Michael J. Hartshorn et al. · Proteins Structure Function and Bioinformatics · 2003 · 3K citations · Full text
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis, Jeremy P. Hunt, Sanna Herrgård et al. · Nature Biotechnology · 2011 · 2.4K citations · Full text
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
K M Tewey, Thomas C. Rowe, Liu Yang et al. · Science · 1984 · 1.5K citations
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
Chyuan-Chuan Wu, Tsai‐Kun Li, Lynn Farh et al. · Science · 2011 · 514 citations